Fulvestrant

• Post Date:

  Nov 04,2015

• Expiry Date:

  May 02,2016

• Detailed Description:

  Cas No. :129453-61-8 Quantity: 1Kilograms
  Specs:enterprise standard
  Price:1 USD Kilograms
  Payment Method: TT/DP/WESTUNION
  Fulvestrant
  
  Basic Info.
  Model NO.:129453-61-8 MF:C32H47F5O3S
  MW:606.77 Form:White Powder
  Assay:No Less Than 99% Export Markets:Global
  
  Additional Info.
  Packing: foil bag/tin Origin:China
  Density:1.201 g/cm3 Melting Point:104-106°C
  Boiling Point:674.8 °C at 760 mmHg Usage:Antineoplastic (hormonal)
  
  Applications:
  Many breast cancers are stimulated to grow by the female sex hormones oestrogen and progesterone. These breast cancers are called hormone sensitive or hormone receptor positive. Drugs that block the effects of these hormones can slow or stop the growth of the breast cancer cells. Fulvestrant stops oestrogen getting to the cancer cells by blocking oestrogen receptors and reducing the number of receptors the cancer cell has.
  
  Fulvestrant (Faslodex, AstraZeneca) is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works by down-regulating the estrogen receptor.
  
  Fulvestrant is a selective estrogen receptor down-regulator (SERD). Fulvestrant is indicated for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. The dosing schedule for fulvestrant remains under investigation in an attempt to optimize its effectiveness.
  
  Fulvestrant provided effective second-line therapy in this setting for postmenopausal women who had relapsed or progressed after previous endocrine therapy.
  
  In particular 4 clinical trials in this setting did show similar efficacy to the other hormonal agents (aromatase inhibitors and tamoxifen) with good tolerability profile. Fulvestrant had a lower incidence of joint disorders.
  
  Many breast cancers are stimulated to grow by the female sex hormones oestrogen and progesterone. These breast cancers are called hormone sensitive or hormone receptor positive. Drugs that block the effects of these hormones can slow or stop the growth of the breast cancer cells. Fulvestrant stops oestrogen getting to the cancer cells by blocking oestrogen receptors and reducing the number of receptors the cancer cell has.
  
  OUR ADWANTAGE:
  1, High quality with competitive price:
  1)Standard: Enterprise Standard
  2)We are manufacturer and can provide high quality products with factory price.
  
  2, Fast and safe delivery
  1)Parcel can be sent out in 24 hours after payment. Tracking number available
  2)Secure and discreet shipment. Various transportation methods for your choice.
  3)Customs pass rate ≥99%
  4) We have our own agent/remailer/distributor who can help us ship our products very fast and safe, and we have stock in there for transferring.
  
  3, We have clients throughout the world.
  1)Professional service and rich experience make customers feel at ease, adequate stock and fast delivery meet their desire.
  2)Market feedback and goods feedback will be appreciated, meeting customers's requirement is our responsibility.
  3) High quality, competitive price, fast delivery, first-class service gain the trust and praise from the customers
  
  If you need this or you are interest in this kind of products, you are free to send me email or call me directly, we can talk more about the details of the products.
  No matter you become a customer to me or not at last, you are welcome to inquire from me!
  
  Tel: +86-731-22290218
  Fax: +86-731-22290218
  Cell: +8618188938018
  E-mail: YCWlb031@yccreate.com
  

• CAS Registry Number:

  129453-61-8

• Synonyms:

  ;(7a,17b)-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol;(7alpha,17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol;(17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol;Faslodex;

• Molecular Formula:

  C₃₂H₄₇F₅O₃S

• Molecular Weight:

  606.7708

• Molecular Structure:

  

• Company:

  Zhuzhou Yuancheng Hezhong Technology Development Co., Ltd     [ China ]        

• Contact:

  huangtao

• Tel:

  8618188938010

• Fax:

  027-68886696-899

• Email:

  andytao001@chembj.com